Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.
Schnitzbauer AA, Zuelke C, Graeb C, Rochon J, Bilbao I, Burra P, de Jong KP, Duvoux C, Kneteman NM, Adam R, Bechstein WO, Becker T, Beckebaum S, Chazouillères O, Cillo U, Colledan M, Fändrich F, Gugenheim J, Hauss JP, Heise M, Hidalgo E, Jamieson N, Königsrainer A, Lamby PE, Lerut JP, Mäkisalo H, Margreiter R, Mazzaferro V, Mutzbauer I, Otto G, Pageaux GP, Pinna AD, Pirenne J, Rizell M, Rossi G, Rostaing L, Roy A, Turrion VS, Schmidt J, Troisi RI, van Hoek B, Valente U, Wolf P, Wolters H, Mirza DF, Scholz T, Steininger R, Soderdahl G, Strasser SI, Jauch KW, Neuhaus P, Schlitt HJ, Geissler EK. Schnitzbauer AA, et al. Among authors: fandrich f. BMC Cancer. 2010 May 11;10:190. doi: 10.1186/1471-2407-10-190. BMC Cancer. 2010. PMID: 20459775 Free PMC article. Clinical Trial.
Immunosuppression following intestinal transplantation.
Mueller AR, Pascher A, Platz KP, Braun F, Fändrich F, Rayes N, Seehofer D, Radtke C, Neuhaus P, Kremer B. Mueller AR, et al. Among authors: fandrich f. Transplant Proc. 2004 Mar;36(2):325-8. doi: 10.1016/j.transproceed.2003.12.017. Transplant Proc. 2004. PMID: 15050147
Toward cell-based therapy of type I diabetes.
Kabelitz D, Geissler EK, Soria B, Schroeder IS, Fändrich F, Chatenoud L. Kabelitz D, et al. Among authors: fandrich f. Trends Immunol. 2008 Feb;29(2):68-74. doi: 10.1016/j.it.2007.11.001. Epub 2008 Jan 7. Trends Immunol. 2008. PMID: 18182324
Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells.
Hutchinson JA, Roelen D, Riquelme P, Brem-Exner BG, Witzke O, Philipp T, Matthäi M, Gövert F, Claas FH, Westphal E, Kunzendorf U, Geissler EK, Fändrich F. Hutchinson JA, et al. Among authors: fandrich f. Transpl Int. 2008 Aug;21(8):808-13. doi: 10.1111/j.1432-2277.2008.00712.x. Epub 2008 Jul 10. Transpl Int. 2008. PMID: 18573140 Free article.
A cell-based approach to the minimization of immunosuppression in renal transplantation.
Hutchinson JA, Brem-Exner BG, Riquelme P, Roelen D, Schulze M, Ivens K, Grabensee B, Witzke O, Philipp T, Renders L, Humpe A, Sotnikova A, Matthäi M, Heumann A, Gövert F, Schulte T, Kabelitz D, Claas FH, Geissler EK, Kunzendorf U, Fändrich F. Hutchinson JA, et al. Among authors: fandrich f. Transpl Int. 2008 Aug;21(8):742-54. doi: 10.1111/j.1432-2277.2008.00692.x. Epub 2008 Jul 10. Transpl Int. 2008. PMID: 18573141 Free article. Clinical Trial.
Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible.
Hutchinson JA, Gövert F, Riquelme P, Bräsen JH, Brem-Exner BG, Matthäi M, Schulze M, Renders L, Kunzendorf U, Geissler EK, Fändrich F. Hutchinson JA, et al. Among authors: fandrich f. Clin Transplant. 2009 Jan-Feb;23(1):140-5. doi: 10.1111/j.1399-0012.2008.00953.x. Clin Transplant. 2009. PMID: 19200227
140 results